HE homepage

Ed Gaines, JD, CCP, vice president of regulatory affairs and industry liaison, Zotec Partners, discusses the No Surprises Act on radiology at the Radiological Society of North America (RSNA) 2022 meeting. Gaines works with RSNA on billing and Medicare issues and spoke in sessions at the RSNA 2022 meeting. Insurance companies have weaponized the No Surprises Act in an effort to cut their costs, he said.

Ed Gaines, JD, CCP, vice president of regulatory affairs and industry liaison, Zotec Partners, discusses the impact of the No Surprises Act on healthcare and medical imaging at the RSNA 2022 meeting

insurance payer payment insurer

Prior authorization, which requires healthcare providers to get approval from insurance providers before giving certain treatments to patients, has been long-hailed as extremely burdensome to physicians, even causing delays in patient care.

AI is still one of the key technologies on the floor that many radiologists want to learn more about. A product rep discussing breast automated detection AI in the crowded Lunit booth at RSNA 2022.

Here are some interesting new technologies and key trends from the vast expo floor at the Radiological Society of North America 2022 meeting.

mergers and acquisitions M&A puzzle

Advocate Health, the newly combined entity of Advocate Aurora Health and Atrium Health, is now the fifth largest nonprofit health system in the United States.

women burnout

A study that aimed to look at the association between physician burnout and electronic health record message characteristics did not find a strong link, but did reveal opportunities to improve negativity and hostility toward physicians in some messages.

Among general cardiologists, for example, median compensation jumped nearly 8% from 2023 to 2024. Interventional cardiology and electrophysiology saw even larger jumps. Dollar money graphic showing increased finance.

Their financial results are in stark opposition to several dismal reports about hospitals’ operating environments.

Around the web

The approval, made as part of a special FDA pilot program, took just 50 days.